Form 4: Bausch Health Director Kavanagh Receives and Disposes of Shares in Recent Transaction

Director Sarah B. Kavanagh reports acquisition and disposal of Bausch Health Companies Inc. shares related to restricted share units.

Summary

• On May 16, 2025, Sarah B. Kavanagh, a director of Bausch Health Companies Inc., acquired 54,347 common shares as part of a restricted share unit (RSU) award.
• The RSUs were granted to non-employee directors following their election at the Issuer's Annual Meeting of Shareholders.
• These RSUs have a grant date value of $250,000, vest immediately prior to the next Annual Meeting, and are settled in common shares.
• Following the transaction, Kavanagh directly owns 236,359 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral to positive as it aligns interests. There are no indications of negative sentiment.

Positives

• The RSU grant aligns director compensation with shareholder interests, as the value is tied to the company's stock performance.

Future Outlook

The RSUs will vest immediately prior to the Issuer's next Annual Meeting of Shareholders and will be settled in common shares of the Issuer.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• RSU grants are a common form of compensation for directors in publicly traded companies, aligning their interests with those of shareholders.
• The vesting schedule of immediately prior to the next annual meeting is a typical structure for director RSU grants.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

Keywords

Bausch Health, Director, RSU, Share Ownership, Form 4, Kavanagh, BHC, Securities